Research
Looking beyond opioids
February 7, 2025
A revolution in pain exploration has been launched with the school’s new Center for Pain Therapeutics and Addiction Research. Interdisciplinary collaboration is helping investigators study non-opioid treatments for chronic pain and how diet and stem cells can help alleviate suffering.
The future of healing is regenerative
February 7, 2025
UT Health San Antonio is breaking new ground in its search for innovative treatments for oral diseases. The newly created Center for Regenerative Sciences is already probing solutions to restore salivary gland function in head and neck cancer patients and replicating bone with 3D-printed scaffolds. The center’s collaborative efforts hold the promise of new, life-changing therapies.
When ‘time is brain’
December 9, 2024
In the world of stroke care, every minute counts. Lee Birnbaum, MD, professor in the departments of neurology and neurosurgery in the Joe R. and Teresa Lozano Long School of Medicine, sheds light on the latest developments in emergency treatments, post-stroke therapies and community education aimed at enhancing patient outcomes.
Breaking the grip of migraines
December 9, 2024
Throbbing. Stabbing. Fiery. Electric. Like being in a vice. There are many ways that migraine sufferers describe their pain, but no matter the word to describe it, having migraines is a debilitating condition that often causes significant disruption to a person’s quality of life.
Finding a break in the clouds
December 9, 2024
For some people struggling with their mental health, available treatments can be ineffective, effective for only a short time or cause insufferable side effects. About 30% of people with depression are treatment resistant, meaning they have tried two or more medications or therapies and are still experiencing significant symptoms.
Taming tinnitus
December 9, 2024
It can manifest as a low- or high-pitched tone — a squeal, buzz, roar, chirp or click seemingly coming from one or both ears or in the head. It can dissipate within seconds or be continually present; barely discernable or as loud as a freight train.
Preventing opioid relapse
December 9, 2024
Drug overdoses happen every day, every hour. Yet, few Food and Drug Administration-approved medications are available for opioid use disorder. Methocinnamox, a novel compound for opioid use disorder treatment, advances toward clinical trials.
Understanding and addressing addiction
December 9, 2024
For a health condition as complex as substance use disorder, there are no simple solutions. But the possibilities for addressing the vexing health crisis stemming from substance use and addiction substantially increase when an intentional strategic model for a system of care is applied to create a scaffold of interlinking functional practices.
The search to prevent Alzheimer’s
December 9, 2024
Investigators are testing a new drug for its potential to slow and prevent the disease By Jessica Binkley Lain Alzheimer’s disease continues to challenge medical science with its complex and devastating effects on cognition and memory. In a significant stride forward, the Food and Drug Administration recently approved lecanemab as a promising new compound found […]
The evolution of epilepsy care
December 9, 2024
Epilepsy, a neurological condition characterized by recurrent seizures, affects approximately 3 million people in the United States — about 1% of the nation’s population — and is considered one of the most prevalent neurological disorders.
Mapping brain health
December 9, 2024
While most people focus on what they see during brain imaging, Peter Fox, MD, director of the Research Imaging Institute at The University of Texas Health Science Center at San Antonio, will tell you that the real value is in the mathematics and quantitative assessments behind those pictures.